The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Gemcitabine Market Research Report 2025
Synopsis
Gemcitabine (CAS 95058-81-4), C9H11F2N3O4, the formula weight is 263.2, and its form is white to yellow powder.
The global Gemcitabine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Gemcitabine is used as a second-line treatment for patients with advanced pancreatic cancer after fluorouracil failure, and can improve the quality of life of patients. Secondly, it is a first-line application for locally advanced (stage III) and already metastatic (stage IV) non-small cell lung cancer.
This report aims to provide a comprehensive presentation of the global market for Gemcitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine.
Report Scope
The Gemcitabine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gemcitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lilly France
Hansoh Pharma
Hisun Pharma
Pude Pharma
Qilu Pharma
Jari Pharma
HPGC
Yibantian Pharma
Actavis
Accord Healthcare
Mylan
Novartis
Salius Pharma
Segment by Type
1g/Vial
200mg/Vial
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gemcitabine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Gemcitabine (CAS 95058-81-4), C9H11F2N3O4, the formula weight is 263.2, and its form is white to yellow powder.
The global Gemcitabine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Gemcitabine is used as a second-line treatment for patients with advanced pancreatic cancer after fluorouracil failure, and can improve the quality of life of patients. Secondly, it is a first-line application for locally advanced (stage III) and already metastatic (stage IV) non-small cell lung cancer.
This report aims to provide a comprehensive presentation of the global market for Gemcitabine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gemcitabine.
Report Scope
The Gemcitabine market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Gemcitabine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gemcitabine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lilly France
Hansoh Pharma
Hisun Pharma
Pude Pharma
Qilu Pharma
Jari Pharma
HPGC
Yibantian Pharma
Actavis
Accord Healthcare
Mylan
Novartis
Salius Pharma
Segment by Type
1g/Vial
200mg/Vial
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Gemcitabine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Gemcitabine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Gemcitabine Market Overview
1.1 Product Overview and Scope of Gemcitabine
1.2 Gemcitabine Segment by Type
1.2.1 Global Gemcitabine Market Value Comparison by Type (2024-2030)
1.2.2 1g/Vial
1.2.3 200mg/Vial
1.3 Gemcitabine Segment by Application
1.3.1 Global Gemcitabine Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Gemcitabine Market Size Estimates and Forecasts
1.4.1 Global Gemcitabine Revenue 2019-2030
1.4.2 Global Gemcitabine Sales 2019-2030
1.4.3 Global Gemcitabine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Gemcitabine Market Competition by Manufacturers
2.1 Global Gemcitabine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Gemcitabine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Gemcitabine Average Price by Manufacturers (2019-2024)
2.4 Global Gemcitabine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Gemcitabine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gemcitabine, Product Type & Application
2.7 Gemcitabine Market Competitive Situation and Trends
2.7.1 Gemcitabine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gemcitabine Players Market Share by Revenue
2.7.3 Global Gemcitabine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gemcitabine Retrospective Market Scenario by Region
3.1 Global Gemcitabine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Gemcitabine Global Gemcitabine Sales by Region: 2019-2030
3.2.1 Global Gemcitabine Sales by Region: 2019-2024
3.2.2 Global Gemcitabine Sales by Region: 2025-2030
3.3 Global Gemcitabine Global Gemcitabine Revenue by Region: 2019-2030
3.3.1 Global Gemcitabine Revenue by Region: 2019-2024
3.3.2 Global Gemcitabine Revenue by Region: 2025-2030
3.4 North America Gemcitabine Market Facts & Figures by Country
3.4.1 North America Gemcitabine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Gemcitabine Sales by Country (2019-2030)
3.4.3 North America Gemcitabine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Gemcitabine Market Facts & Figures by Country
3.5.1 Europe Gemcitabine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Gemcitabine Sales by Country (2019-2030)
3.5.3 Europe Gemcitabine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gemcitabine Market Facts & Figures by Country
3.6.1 Asia Pacific Gemcitabine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Gemcitabine Sales by Country (2019-2030)
3.6.3 Asia Pacific Gemcitabine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Gemcitabine Market Facts & Figures by Country
3.7.1 Latin America Gemcitabine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Gemcitabine Sales by Country (2019-2030)
3.7.3 Latin America Gemcitabine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gemcitabine Market Facts & Figures by Country
3.8.1 Middle East and Africa Gemcitabine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Gemcitabine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Gemcitabine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Gemcitabine Sales by Type (2019-2030)
4.1.1 Global Gemcitabine Sales by Type (2019-2024)
4.1.2 Global Gemcitabine Sales by Type (2025-2030)
4.1.3 Global Gemcitabine Sales Market Share by Type (2019-2030)
4.2 Global Gemcitabine Revenue by Type (2019-2030)
4.2.1 Global Gemcitabine Revenue by Type (2019-2024)
4.2.2 Global Gemcitabine Revenue by Type (2025-2030)
4.2.3 Global Gemcitabine Revenue Market Share by Type (2019-2030)
4.3 Global Gemcitabine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Gemcitabine Sales by Application (2019-2030)
5.1.1 Global Gemcitabine Sales by Application (2019-2024)
5.1.2 Global Gemcitabine Sales by Application (2025-2030)
5.1.3 Global Gemcitabine Sales Market Share by Application (2019-2030)
5.2 Global Gemcitabine Revenue by Application (2019-2030)
5.2.1 Global Gemcitabine Revenue by Application (2019-2024)
5.2.2 Global Gemcitabine Revenue by Application (2025-2030)
5.2.3 Global Gemcitabine Revenue Market Share by Application (2019-2030)
5.3 Global Gemcitabine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Lilly France
6.1.1 Lilly France Corporation Information
6.1.2 Lilly France Description and Business Overview
6.1.3 Lilly France Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Lilly France Gemcitabine Product Portfolio
6.1.5 Lilly France Recent Developments/Updates
6.2 Hansoh Pharma
6.2.1 Hansoh Pharma Corporation Information
6.2.2 Hansoh Pharma Description and Business Overview
6.2.3 Hansoh Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Hansoh Pharma Gemcitabine Product Portfolio
6.2.5 Hansoh Pharma Recent Developments/Updates
6.3 Hisun Pharma
6.3.1 Hisun Pharma Corporation Information
6.3.2 Hisun Pharma Description and Business Overview
6.3.3 Hisun Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Hisun Pharma Gemcitabine Product Portfolio
6.3.5 Hisun Pharma Recent Developments/Updates
6.4 Pude Pharma
6.4.1 Pude Pharma Corporation Information
6.4.2 Pude Pharma Description and Business Overview
6.4.3 Pude Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Pude Pharma Gemcitabine Product Portfolio
6.4.5 Pude Pharma Recent Developments/Updates
6.5 Qilu Pharma
6.5.1 Qilu Pharma Corporation Information
6.5.2 Qilu Pharma Description and Business Overview
6.5.3 Qilu Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qilu Pharma Gemcitabine Product Portfolio
6.5.5 Qilu Pharma Recent Developments/Updates
6.6 Jari Pharma
6.6.1 Jari Pharma Corporation Information
6.6.2 Jari Pharma Description and Business Overview
6.6.3 Jari Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jari Pharma Gemcitabine Product Portfolio
6.6.5 Jari Pharma Recent Developments/Updates
6.7 HPGC
6.6.1 HPGC Corporation Information
6.6.2 HPGC Description and Business Overview
6.6.3 HPGC Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 HPGC Gemcitabine Product Portfolio
6.7.5 HPGC Recent Developments/Updates
6.8 Yibantian Pharma
6.8.1 Yibantian Pharma Corporation Information
6.8.2 Yibantian Pharma Description and Business Overview
6.8.3 Yibantian Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Yibantian Pharma Gemcitabine Product Portfolio
6.8.5 Yibantian Pharma Recent Developments/Updates
6.9 Actavis
6.9.1 Actavis Corporation Information
6.9.2 Actavis Description and Business Overview
6.9.3 Actavis Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Actavis Gemcitabine Product Portfolio
6.9.5 Actavis Recent Developments/Updates
6.10 Accord Healthcare
6.10.1 Accord Healthcare Corporation Information
6.10.2 Accord Healthcare Description and Business Overview
6.10.3 Accord Healthcare Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Accord Healthcare Gemcitabine Product Portfolio
6.10.5 Accord Healthcare Recent Developments/Updates
6.11 Mylan
6.11.1 Mylan Corporation Information
6.11.2 Mylan Gemcitabine Description and Business Overview
6.11.3 Mylan Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Mylan Gemcitabine Product Portfolio
6.11.5 Mylan Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Corporation Information
6.12.2 Novartis Gemcitabine Description and Business Overview
6.12.3 Novartis Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Novartis Gemcitabine Product Portfolio
6.12.5 Novartis Recent Developments/Updates
6.13 Salius Pharma
6.13.1 Salius Pharma Corporation Information
6.13.2 Salius Pharma Gemcitabine Description and Business Overview
6.13.3 Salius Pharma Gemcitabine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Salius Pharma Gemcitabine Product Portfolio
6.13.5 Salius Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gemcitabine Industry Chain Analysis
7.2 Gemcitabine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gemcitabine Production Mode & Process
7.4 Gemcitabine Sales and Marketing
7.4.1 Gemcitabine Sales Channels
7.4.2 Gemcitabine Distributors
7.5 Gemcitabine Customers
8 Gemcitabine Market Dynamics
8.1 Gemcitabine Industry Trends
8.2 Gemcitabine Market Drivers
8.3 Gemcitabine Market Challenges
8.4 Gemcitabine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
